Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Losartan add-on in inotrope-dependent heart failure
NCT01857999Phase 4Completed
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of losartan in heart failure (HF). Primary endpoint: B-type natriuretic peptide at 7 days. Started Sep 2008; status: completed.
02
Drugs
losartan
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01857999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01857999.